Aquilabio.com
About Aquilabio.com
Aquilabio.com is a Healthcare company founded in 2022, and was acquired by Agenusbio in August 2000. Human and animal healthcare products for immunological diseases are developed. The company was acqui-hired. Its focus areas include Life Sciences, Immunology, Drugs and Diversified.
Company details
Aquilabio.com was founded in 2022 and operates in the biotechnology sector, focusing on human and animal healthcare. Products such as Quilvax-M for bovine mastitis management, Quilimmune-M for malaria prevention, and Quilimmune-P for pneumococcal infection prevention are developed. Additional solutions for infectious diseases, cancers, and autoimmune disorders are created using immune enhancement technologies. Operations emphasize product development without specified geographic focus.
- Stage Acquired
- SectorsHealthcare
- Website aquilabio.com
- Acquired by Agenusbio (Aug 2000)
Investors in Aquilabio.com
Aquilabio.com has secured backing from 1 investor. Prominent investors backing the company include Agenusbio.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Developer of immunotherapies to treat cancer | 1994 | agenusbio.com | Lexington, United States |
Investor details for Aquilabio.com
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Aquilabio.com
2 dated milestones of Aquilabio.com across 22 years, from founding to its latest funding, stage changes and deals.
- Exit Acquired by Agenusbio.
- Founded Aquilabio.com is founded.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Aquilabio.com
Aquilabio.com was founded in 2022.
Aquilabio.com was founded in 2022 and operates in the biotechnology sector, focusing on human and animal healthcare. Products such as Quilvax-M for bovine mastitis management, Quilimmune-M for malaria prevention, and Quilimmune-P for pneumococcal infection prevention are developed. Additional solutions for infectious diseases, cancers, and autoimmune disorders are created using immune enhancement technologies. Operations emphasize product development without specified geographic focus.
Aquilabio.com has 1 investor. Key investors include Agenusbio.
Yes. Aquilabio.com was acquired by Agenusbio in August 2000.